The Majority of Gout Patients on Uric Acid Lowering Therapy Fail to Achieve Control of Serum Urate Levels Despite the Availability of Newer Treatment Options Such as Takeda`s Uloric, Menarini/Ipsen`s Adenuric and Savient Pha